diabetestalk.net

Researchers Emphasize Community In Diabetes Care

Researchers emphasize community in diabetes care

Researchers emphasize community in diabetes care

Two UNM researchers are taking a community-based approach to studying diabetes self-management for low income Hispanic patients, and they have a $2.3 million grant to fund their research.
Janet Page-Reeves, lead researcher on the study, said the pair previously worked on a smaller project where they concluded that there are many people in Albuquerque’s Latino community with diabetes, and there is a high rate of people who go undiagnosed.
Page-Reeves said the survey found that, out of 100 participants, 59 tested positive for diabetes or prediabetes but only 26 knew about their condition.
The study’s community lead, Lidia Regino, took that information and turned it into a program, which is in its fifth year. One Hope Centro de Vida Health Center offers a five-part class where patients learn about diabetes management from pharmacy or medical students and then meet with medical providers to discuss their individual management plan, she said.
“Over time, Lidia had identified that she felt their work at the clinic was having really...amazing results. They were seeing people change their behavior, they felt like it was really working,” Page-Reeves said.
So the pair decided to study the program’s success with a scientific approach, she said.
Their hypothesis is that a culturally and contextually situated health promotion program will be more successful for individual patients, Page-Reeves said.
“If you have diabetes and I tell you, ‘You should join a gym,’ but you are low income, that’s not going to happen,” she said. “If I tell you to walk in your neighborhoo Continue reading

Rate this article
Total 1 ratings
To Donald Trump, From an American With Diabetes

To Donald Trump, From an American With Diabetes

Dear President Trump,
Today you were sworn into become President of the United States.
As you were being sworn in, thousands of insulin dependent diabetics had to make a choice. Should they take a full dose of insulin and ensure their blood sugars don’t go high, or should they save some in an effort to try and make it through the month? I am one of the lucky ones, I have the resources to have private insurance. However, even with private insurance my Novolog insulin runs me over $400 out of pocket. Now imagine if I didn’t have insurance, that number would be in the thousands.
Sir, there are millions of Americans who depend on the Affordable Care Act to survive. For these Americans, the ACA isn’t merely some bill or something to argue over in the Senate, it’s a matter of life and death.
Please Donald, before you repeal the ACA, be sure to have a replacement. Why don’t you incorporate the millions of Americans who live with a chronic illness into the discussion of a replacement? The ACA isn’t perfect, but it has saved lives.
Drug prices are still too high, and far too many Americans go without vital medication because they cannot afford it, but the ACA has granted millions access to affordable health insurance, something that seemed like a dream 10 years ago.
Donald, I would invite you to listen to those with chronic illnesses and other health problems. Listen to the American people.
After all, didn’t the American people put you in office in the first place?
Lead photo by Thinkstock Images Continue reading

Popular Diabetes Medication Linked to Kidney Failure  Americas Lawyer

Popular Diabetes Medication Linked to Kidney Failure Americas Lawyer


Popular Diabetes Medication Linked to Kidney Failure Americas Lawyer
According to latest data from the Centers for Disease Control, more than 29-million Americans suffer from diabetes, and nearly one of four people with the disease arent even aware that they have it. Even worse, as many as 86-million Americans currently suffer from pre-diabetes, and if preemptive measures arent taken they too will be diagnosed with full blown diabetes in a matter of years. With so many people suffering from both type one and type two diabetes, Big Pharma saw an opportunity to make a huge profit. In the rush to cash in on the diabetic epidemic they cut corners. They created a product thats causing as much harm, if not more, than the actual disease itself. That product is called Invokana.
Papantonio: According to latest data from the Centers for Disease Control, more than 29-million Americans suffer from diabetes, and nearly one of four people with the disease arent even aware that they have it. Even worse, as many as 86-million Americans currently suffer from pre-diabetes, and if preemptive measures arent taken they too will be diagnosed with full blown diabetes in a matter of years. With so many people suffering from both type one and type two diabetes, Big Pharma saw an opportunity to make a huge profit. In the rush to cash in on the diabetic epidemic they cut corners. They created a product thats causing as much harm, if not more, than the actual disease itself. That product is called Invokana.
Invokana was developed by Janssen, an offshoot of Johnson & Johnson. Unlike other diabete Continue reading

Remote type 2 education platform selected for NHS Innovation

Remote type 2 education platform selected for NHS Innovation

A low-cost, online self-management platform for people with diabetes and a fully remote programme of type 2 diabetes structured education are among the latest technologies selected to join the NHS Innovation Accelerator (NIA).
A total of 11 innovations have been selected as part of an event to launch the third year of this NHS England initiative, delivered in partnership with England’s 15 Academic Health Science Networks (AHSNs).
The NIA has supported the uptake and spread of 25 high-impact, evidence-based innovations across 799 NHS organisations since it launched in July 2015.
Each of the new innovations joining the NIA this year offer solutions to key challenges in primary care, urgent and emergency care and mental health. Recruitment onto the NIA follows an international call and robust selection process, including review by a collegiate of over 100 assessors and the National Institute for Health and Care Excellence (NICE).
Simon Stevens, NHS England chief executive said: “Modern medicine is on the cusp of a huge shift in how care is delivered, and practical innovations like these show how NHS patients will now directly benefit. More tests and patient monitoring will be done at home or on the move, without the need to pitch up to a doctor’s appointment or hospital outpatients.”
My Diabetes My Way is an interactive website for people with condition, providing comprehensive information about medication, self-management and lifestyle. online self-management platform for people with diabetes. Recent figures suggested that 88 per cent of users, felt it had helped them Continue reading

Animal Models of Type 2 Diabetes: The GK Rat

Animal Models of Type 2 Diabetes: The GK Rat


Animal Models of Type 2 Diabetes: The GK Rat
Animal Models of Type 2 Diabetes: The GK Rat
Studying the long-term complications of diabetic pathology is more relevant than ever, driving increased interest in animal models of type 2 diabetes. According to the World Health Organization (WHO) the number of people with diabetes (includes both type 1 and type 2) has risen from 108 million in 1980 to 422 million in 2014.
"[Diabetes] is a major cause of blindness, kidney failure, heart attacks, stroke, and lower limb amputation. Over time, diabetes can damage the heart, blood vessels, eyes, kidneys, and nerves. Adults with diabetes have a 2-3-fold increased risk of heart attacks and strokes. Combined with reduced blood flow, neuropathy in the feet increases the chance of foot ulcers, infection and eventual need for limb amputation. Diabetic retinopathy is an important cause of blindness and occurs as a result of long-term accumulated damage to the small blood vessels in the retina. 2.6% of global blindness can be attributed to diabetes. Diabetes is among the leading causes of kidney failure." (WHO Media Center, 2016).
There are a variety of mouse and rat models which can be used to study aspects of type 2 diabetes:
Varying aspects and severity of complications
+ More robust diet induced obesity in C57BL/6NTac (Gareski T, 2009)
Studying Long-term Pathology in Animal Models of Type 2 Diabetes
The ob/ob and db/db mice, as well as the Zucker Diabetic Fatty rat, are all well-characterized and frequently-used diabetic models which exhibit a mutation in the leptin (ob/ob) or lep Continue reading

No more pages to load

Popular Articles

  • Israeli researchers discover shrub that can treat diabetes

    Israeli researchers have found that a plant that grows in Israel, as well as in other parts of the Middle East, is effective in treating diabetes. Dr. Jonathan Gorelick of the Judea Research and Development Center will present the results of his study of Chiliadenus iphionoides (sharp varthemia), an aromatic shrub that grows in Israel and throughout the Middle East, at the 25th Judea and Samaria R ...

  • New insulin pill developed by American researchers that could treat type 1 diabetes

    American researchers have developed an insulin pill that could provide a less painful way for people with type 1 diabetes to control their blood sugar levels. This new technology is known as a Cholestosome, which was reported on this week at the 252nd National Meeting and Exposition of the American Chemical Society (ACS). Mary McCourt, a researcher from Niagara University, explains that a Cholesto ...

  • Researchers Are Putting This Potential Diabetes Cure to the Test in a 3-Year-Long Trial

    There just might be some very exciting news on the horizon for people with diabetes! If you’ve suffer from the condition, you’ve likely been warned of the risk of high blood pressure and heart disease. And if you have high blood pressure, you’ve probably heard of Verapamil, a rather common blood pressure medication. Well, it’s recently served another purpose: researchers have recently used ...

  • Researchers identify gene variants linked to both type 2 diabetes and CHD risk

    Type 2 diabetes (T2D) has become a global epidemic affecting more than 380 million people worldwide; yet there are knowledge gaps in understanding the etiology of type-2 diabetes. T2D is also a significant risk factor for coronary heart disease (CHD), but the biological pathways that explain the connection have remained somewhat murky. Now, in a large analysis of genetic data, published on August ...

  • An unlikely tool to combat diabetes: chocolate, say researchers

    But here’s the thing: BYU researchers have discovered certain compounds found in cocoa can actually help your body release more insulin and respond to increased blood glucose better. Insulin is the hormone that manages glucose, the blood sugar that reaches unhealthy levels in diabetes. Of course, there’s a catch. “You probably have to eat a lot of cocoa, and you probably don’t want it to h ...

  • 'Clear promise': Diabetes drug reversed memory loss in mice with Alzheimer's, researchers find

    A team of Chinese and British researchers has discovered that a drug originally created to treat diabetes shows “clear promise” as a treatment for Alzheimer’s disease, since it significantly reversed memory loss in mice. News of the potential breakthrough was published this week in Brain Research. “[The drug shows a] clear promise of being developed into a new treatment for chronic neurode ...

  • Indian Researchers Unravel How a Common Insecticide Can Cause Diabetes

    They found that organophosphates, common in India, are broken down by microbes in the human gut into glucose – and ask us to reconsider their use. In 2010, an American researcher found that when young rats were exposed to very small amounts of compounds that contained molecules of a substance called organophosphates (OPs), they developed early signs of diabetes. Specifically, he found that the o ...

  • Researchers develop contact lens that tells people with diabetes when they need to take medication

    Researchers are developing a revolutionary contact lens that could change the lives of millions of people suffering from type 1 diabetes. Living with the disease can be stressful as doctors recommend diagnosed patients test their blood four to eight times a day. The lens would use people’s tears to monitor their blood glucose levels, saving them time and potentially improving their health. “I ...

  • Researchers Make Progress on a Pill to Stop Type 2 Diabetes

    Pharmaceutical researchers are one step closer to making a pill that can reverse the symptoms of type 2 diabetes. They published their research in the journal Nature Chemical Biology. Diabetes and its complications are a major issue within the United States and abroad. In 2012, the American Diabetes Association reported that 29.1 million Americans, or 9.3 percent of the population, lived with diab ...

Related Articles